IDENTIFICATION OF STREPTOCOCCUS MILLERI GROUP (SMG) BACTERIA BY BIOCHEMICAL AND MOLECULAR METHODS

Objective: The aim of this study was to differentiate the strains of Streptococcus milleri group (SMG) bacteria using molecular, biochemical and semi-automated techniques and to investigate the results of susceptibility to commonly used antibiotics in treatment. It was anticipated that the study wou...

Full description

Saved in:
Bibliographic Details
Main Authors: Gülşen Günel, Bülent Gürler
Format: Article
Language:English
Published: Istanbul University Press 2023-02-01
Series:Sabiad
Subjects:
Online Access:https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/6D1E794DC2094407A05A104CB9501664
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849312273187733504
author Gülşen Günel
Bülent Gürler
author_facet Gülşen Günel
Bülent Gürler
author_sort Gülşen Günel
collection DOAJ
description Objective: The aim of this study was to differentiate the strains of Streptococcus milleri group (SMG) bacteria using molecular, biochemical and semi-automated techniques and to investigate the results of susceptibility to commonly used antibiotics in treatment. It was anticipated that the study would draw attention to some important points about SMG bacteria and to determine their epidemiological importance. Materials and method: A total of 100 streptococcal bacteria were included in our study. Biochemical tests and the API 20 STREP semiautomatic identification kit were used for species identification. Species identifications were confirmed by amplification of the target gene regions (HYL-MIX-U, HLY-INT-D, HLY-CC-D, 16S-ANG-U, 16S-ANG-D, ILY-4DFw, ILYwholeC Bw) by polymerase chain reaction (PCR). Results: Voges-Proskauer tests of all strains were positive, whereas hippurate hydrolysis and pyrrolidinyl arylamidase (PYR) tests were negative. All strains were evaluated in terms of Lancefield group antigen, and it was found that 42% were G, 26% were F, and 5% were C group antigen. It was not possible to determine antigen type with Lancefield group antigens in 27% of the strains. All of the isolates were found to be susceptible to vancomycin, ceftriaxone, cefepime, cefotaxime, levofloxacin, and linezolid. Erythromycin, clindamycin, tetracycline, and chloramphenicol resistance was found in 16%, 6%, 5%, and %1 of the isolates, respectively. Ampicillin and penicillin resistance were determined by the E-test method. One Streptococcus anginosus strain was resistant to ampicillin and penicillin, and two S. anginosus isolates were found to be intermediately susceptible to ampicillin. According to API 20 STREP results, 41% of the isolates were identified as genus level, 45% were S. anginosus, 5% were Streptococcus constellatus, and 1% were Streptococcus intermedius. Multiplex polymerase chain reaction (PCR) results were found to be 56% S. anginosus, 24% S. constellatus, and 8% S. intermedius. No band was detected in 12% of the strains. It has been determined that the biochemical identification scheme of the Streptococcus milleri group has not yet been fully defined. According to the antibiotic susceptibility results, the development of resistance in SMG is not critical. Commercial kits are unsatisfactory in identifying this group, and the studies should be supported with molecular methods.
format Article
id doaj-art-c4c91e76effc46f69cd815af4f2e00d9
institution Kabale University
issn 2651-4060
language English
publishDate 2023-02-01
publisher Istanbul University Press
record_format Article
series Sabiad
spelling doaj-art-c4c91e76effc46f69cd815af4f2e00d92025-08-20T03:53:07ZengIstanbul University PressSabiad2651-40602023-02-0161737910.26650/JARHS2023-1164336123456IDENTIFICATION OF STREPTOCOCCUS MILLERI GROUP (SMG) BACTERIA BY BIOCHEMICAL AND MOLECULAR METHODSGülşen Günel0https://orcid.org/0000-0003-1574-0231Bülent Gürler1https://orcid.org/0000-0002-6433-5198İstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Sağlık ve Teknoloji Üniversitesi, Istanbul, TurkiyeObjective: The aim of this study was to differentiate the strains of Streptococcus milleri group (SMG) bacteria using molecular, biochemical and semi-automated techniques and to investigate the results of susceptibility to commonly used antibiotics in treatment. It was anticipated that the study would draw attention to some important points about SMG bacteria and to determine their epidemiological importance. Materials and method: A total of 100 streptococcal bacteria were included in our study. Biochemical tests and the API 20 STREP semiautomatic identification kit were used for species identification. Species identifications were confirmed by amplification of the target gene regions (HYL-MIX-U, HLY-INT-D, HLY-CC-D, 16S-ANG-U, 16S-ANG-D, ILY-4DFw, ILYwholeC Bw) by polymerase chain reaction (PCR). Results: Voges-Proskauer tests of all strains were positive, whereas hippurate hydrolysis and pyrrolidinyl arylamidase (PYR) tests were negative. All strains were evaluated in terms of Lancefield group antigen, and it was found that 42% were G, 26% were F, and 5% were C group antigen. It was not possible to determine antigen type with Lancefield group antigens in 27% of the strains. All of the isolates were found to be susceptible to vancomycin, ceftriaxone, cefepime, cefotaxime, levofloxacin, and linezolid. Erythromycin, clindamycin, tetracycline, and chloramphenicol resistance was found in 16%, 6%, 5%, and %1 of the isolates, respectively. Ampicillin and penicillin resistance were determined by the E-test method. One Streptococcus anginosus strain was resistant to ampicillin and penicillin, and two S. anginosus isolates were found to be intermediately susceptible to ampicillin. According to API 20 STREP results, 41% of the isolates were identified as genus level, 45% were S. anginosus, 5% were Streptococcus constellatus, and 1% were Streptococcus intermedius. Multiplex polymerase chain reaction (PCR) results were found to be 56% S. anginosus, 24% S. constellatus, and 8% S. intermedius. No band was detected in 12% of the strains. It has been determined that the biochemical identification scheme of the Streptococcus milleri group has not yet been fully defined. According to the antibiotic susceptibility results, the development of resistance in SMG is not critical. Commercial kits are unsatisfactory in identifying this group, and the studies should be supported with molecular methods.https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/6D1E794DC2094407A05A104CB9501664lancefield group antigenstreptococcus milleri groupvogesproskauerpcrapi
spellingShingle Gülşen Günel
Bülent Gürler
IDENTIFICATION OF STREPTOCOCCUS MILLERI GROUP (SMG) BACTERIA BY BIOCHEMICAL AND MOLECULAR METHODS
Sabiad
lancefield group antigen
streptococcus milleri group
vogesproskauer
pcr
api
title IDENTIFICATION OF STREPTOCOCCUS MILLERI GROUP (SMG) BACTERIA BY BIOCHEMICAL AND MOLECULAR METHODS
title_full IDENTIFICATION OF STREPTOCOCCUS MILLERI GROUP (SMG) BACTERIA BY BIOCHEMICAL AND MOLECULAR METHODS
title_fullStr IDENTIFICATION OF STREPTOCOCCUS MILLERI GROUP (SMG) BACTERIA BY BIOCHEMICAL AND MOLECULAR METHODS
title_full_unstemmed IDENTIFICATION OF STREPTOCOCCUS MILLERI GROUP (SMG) BACTERIA BY BIOCHEMICAL AND MOLECULAR METHODS
title_short IDENTIFICATION OF STREPTOCOCCUS MILLERI GROUP (SMG) BACTERIA BY BIOCHEMICAL AND MOLECULAR METHODS
title_sort identification of streptococcus milleri group smg bacteria by biochemical and molecular methods
topic lancefield group antigen
streptococcus milleri group
vogesproskauer
pcr
api
url https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/6D1E794DC2094407A05A104CB9501664
work_keys_str_mv AT gulsengunel identificationofstreptococcusmillerigroupsmgbacteriabybiochemicalandmolecularmethods
AT bulentgurler identificationofstreptococcusmillerigroupsmgbacteriabybiochemicalandmolecularmethods